Affiliation:
1. Dept. of Biomedical Engineering; The Ohio State University; Columbus OH
2. William G. Lowrie Dept. of Chemical and Biomolecular Engineering; The Ohio State University; Columbus OH
3. Dept. of Pathology, Division of Neuropathology; The Ohio State University Wexner Medical Center; Columbus OH
4. Dept. of Materials Science and Engineering; The Ohio State University; Columbus OH
5. Dept. of Neurosurgery and Laboratory for Nanomedicine; Geisinger Health System; Danville PA
Funder
National Science Foundation
Center for Affordable Nanoengineering of Polymeric Biomedical Devices (CANPBD)
National Science Foundation-funded Nanoscale Science and Engineering Center (NSEC)
Women in Philanthropy, OSU
H.C. “Slip” Slider Professorship
Pelotonia Graduate Fellowship
Ohio State Metro High School Fellowship
Reference42 articles.
1. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis;Lefranc;J Clin Oncol,2005
2. Review: on TRAIL for malignant glioma therapy?;Kuijlen;Neuropathol Appl Neurobiol,2010
3. New methods for direct delivery of chemotherapy for treating brain tumors;Sawyer;Yale J Biol Med,2006
4. Differential role of proline-rich tyrosine kinase 2 and focal adhesion kinase in determining glioblastoma migration and proliferation;Lipinski;Mol Cancer Res,2003
5. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy;Yuan;Oncogene,2007
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献